Kidney Cancer Diagnostics Market Projected to Experience Major Revenue Boost during the Period till 2022 || Top Market Participants- Myriad Genetics, NeoGenomics Laboratories, NanoString Technologies, Sysmex Corporation, Rosetta Genomics, Illumina, Quest
A new report published by Fact.MR estimates the global kidney cancer diagnostics market to exhibit an impressive expansion at during the forecast period 2017 to 2022. In terms of revenues, the global market for kidney cancer diagnostics will reach nearly US$ 700 Mn by 2022-end.
Request For Free Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=56
Targeted Systemic Therapies for Metastatic Kidney Cancer are Providing Significant Benefits to Survival and Progression
Over the past few years, the diagnosis and management of kidney cancer, or, renal cell carcinoma (RCC), have undergone tremendous transformations. A number of discoveries, studies, and trails are being taken in renal mass biopsy, minimally-invasive thermal ablation, and active surveillance, owing to the surge in diagnosis rate of small renal masses, usually in patients with high morbidity risks related to operative treatment. In addition, targeted systemic therapies associated with metastatic kidney cancer have replaced cytokine-based treatment, providing significant benefits to survival and progression. Recent trails and reviews have cemented the partial nephrectomy’s role as the standard diagnosis-based surgical management option for majority of low-stage masses, and roles of adrenalectomy and lymphadenectomy pertaining to nephrectomy. These incidences are estimated to augment growth of the global kidney cancer diagnostics market.
Kidney cancer has been witnessed to occur majorly in older population. Diagnosis of kidney cancer becomes an intricate task, considering the condition of geriatric patients. While staple diagnostic technologies such as MRI and CT scan continue to play a pivotal role in the global market, patients are also expecting the emergence of all-inclusive diagnosis tests. Medical organizations are also funneling high investments in R&D of kidney cancer diagnostics, particularly to improve the precision of early stage diagnosis tests. Through advancements in medical technology, the global market for kidney cancer diagnostics is also expected to witness emergence of new tests that can simultaneously decelerate the pace of tumor maturation between multiple stages of kidney cancer.
9 Estimations from Fact.MR’s Report on the Global Kidney Cancer Diagnostics Market
Based on end-users, the hospital-associated labs will remain preferred in the market for kidney cancer diagnostics, and are expected to account for the largest revenues over the forecast period.
Independent diagnostic laboratories are estimated to remain the second largest end-users in the global market for kidney cancer diagnostics.
Cancer research institutes will register the fastest expansion in the market during the forecast period.
Immunochemistry tests will remain sought-after in the market for kidney cancer diagnostics, and revenues from these tests will account for US$ 351.8 Mn by 2022-end. Among test type, Immunochemistry test is expected to exhibit the highest CAGR through 2022, followed by the complete blood count test.
Urine analysis is anticipated to remain the second most lucrative tests for diagnosis of kidney cancer across the globe.
Revenues from blood chemistry tests related to kidney cancer diagnostics are expected to remain comparatively lower in the market over the forecast period.
North America will continue to account for the largest revenues in the kidney cancer diagnostics market, followed by Europe.
Market for kidney cancer diagnostics in Europe will register a relatively higher CAGR than in North America throughout the forecast period.
Asia Pacific excluding Japan (APEJ) is expected to remain the fastest growing market for kidney cancer diagnostics over the forecast period.
View Full Report with Table of Content @ https://www.factmr.com/report/56/kidney-cancer-diagnostics-market
The report has also profiled leading players in the global market for kidney cancer diagnostics, which include NeoGenomics Laboratories, Myriad Genetics Inc, NanoString Technologies Inc., Rosetta Genomics, Sysmex Corporation, Illumina, Inc., Roche Holding AG, Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., and Abbott Laboratories.
Hospital-associated Labs will Remain Preferred for Kidney Cancer Diagnostics
On the basis of end-users, hospital-associated labs are estimated to remain preferred for kidney cancer diagnostics, accounting for the largest revenues by 2022-end. Independent diagnostic laboratories will continue to be the second most lucrative end-users in the global kidney cancer diagnostics market. In addition, cancer research institutes are expected to register the highest CAGR in the market through 2022.
Immunochemistry tests will continue to be sought-after for kidney cancer diagnostics, with revenues expected to reach US$ 351.8 Mn by 2022-end. This test type segment is projected to register the highest CAGR in the market through 2022, followed by complete blood count test.
Urine analysis will remain the second largest adopted tests for kidney cancer diagnostics across the globe. However, revenues from blood chemistry tests of kidney cancer diagnostics will continue to be lower as compared to rest of the test segments in the market.
North America to Remain the Largest Market for Kidney Cancer Diagnostics
In terms of revenues, North America is expected to remain the largest market for kidney cancer diagnostics, followed by Europe. However, kidney cancer diagnostics market in Europe will exhibit a comparatively higher CAGR than North America during the forecast period. In addition, Asia Pacific excluding Japan (APEJ) will continue to be the fastest expanding market for kidney cancer diagnostics through 2022.
Table of Content:
Chapter 1 Global Kidney Cancer Diagnostics Market - Executive Summary 13
Chapter 2 Global Kidney Cancer Diagnostics Market Overview 15
2.1 Introduction 15
2.1.1 Global Kidney Cancer Diagnostics Market Taxonomy 15
2.1.2 Global Kidney Cancer Diagnostics Market Definition 15
2.2 Global Kidney Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022 16
2.2.1 Global Kidney Cancer Diagnostics Market Y-o-Y Growth 16
2.3 Global Kidney Cancer Diagnostics Market Dynamics 16
2.3.1 Drivers 16
2.3.2 Restraints 17
2.3.3 Trends 17
2.4 Supply Chain 17
2.5 Epidemiology 17
2.6 List of Distributors 17
2.7 Average Pricing Analysis 18
2.8 Regulations 18
2.9 Key Participants Market Presence (Intensity Map) By Region 18
Chapter 3 Global Kidney Cancer Diagnostics Market Analysis and Forecast By Test Type 19
3.1 Global Kidney Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022 19
3.1.1 Immunohistochemistry Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 19
22.214.171.124 Revenue (US$ Mn) Comparison, By Region 19
126.96.36.199 Market Share Comparison, By Region 21
188.8.131.52 Y-o-Y growth Comparison, By Region 21
3.1.2 Urine Analysis Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 22
184.108.40.206 Revenue (US$ Mn) Comparison, By Region 22
220.127.116.11 Market Share Comparison, By Region 24
18.104.22.168 Y-o-Y growth Comparison, By Region 24
3.1.3 Complete Blood Count Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 25
Grow Your Business From Expert Advice @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=56
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market Insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Cancer Diagnostics Market Projected to Experience Major Revenue Boost during the Period till 2022 || Top Market Participants- Myriad Genetics, NeoGenomics Laboratories, NanoString Technologies, Sysmex Corporation, Rosetta Genomics, Illumina, Quest here
News-ID: 1376061 • Views: 1114
More Releases from Fact.MR
Medical Device Contract Manufacturing Market Set for Strong Growth, Production F …
The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated
Fluid Management Market Expected to Grow Amid Covid-19, Finds Fact.MR
Growing prevalence of chronic disease and an expansion in numbers of geriatric population is leading to an upward facing growth curve for global fluid management market over the period of 2020 to 2025, states Fact.MR. It projects a compound annual growth rate or CAGR of about 5.3% for the market over this period, helping the market push its worth up significantly. It is significant to note here that while number of
Hand Sanitizer Market to Surpass US$ 2.8 Bn, Instant Hand Sanitizer Poised to Ho …
The global hand sanitizer market is set to surpass a value of ~US$ 1.4 Bn in 2020 and is anticipated to cross US$ ~2.8 Bn during the forecast period 2020-2030. The demand for gel-based sanitizer is on the rise as compared to foaming or spray sanitizer. Thus, manufacturers are focusing on developing gel-based sanitizers as they are widely used in multiple end-use industries. With the increased penetration of the online
Medical Marker Bands Market Grows on the back of Their Radiopacity and Cost-effe …
Radiopacity of medical marker bands is giving significant impetus to their demand in the medical marker bands market. The properties of medical marker bands that increases their visibility under fluoroscopes or x-ray during critical procedures is giving an uptick to their sales worldwide. Manufacturers of medical marker bands are also showing a marked preference for cost-effective materials such as polymer and tantalum instead of traditional gold, platinum and palladium. On
More Releases for Kidney
Global Kidney Detox Market Research Report
This report studies the global Kidney Detox market status and forecast, categorizes the global Kidney Detox market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Monster Nutrition(US) Nutrionn(US) Nusapure(US) Thrive Naturals(US) Lally Naturals(US) NOW Foods(US) ReNew Life Formulas, Inc.(USA) Nutracraft(US) American Botanical
Kidney Care Specialists Launch Regional Information Website
Redesigned Kidney Care of Michiana Website Provides Access to Multiple Trusted Resources on Kidney Disease, Dialysis, and Hypertension with Dietary Guidelines Mishawaka, IN; November 1, 2018 – Kidney Care of Michiana has announced the launch of a completely redesigned website with expanded content and providing authoritative information on kidney disease, dialysis and hypertension along with appropriate dietary guidelines via some 40 links available from the new website
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for
3rd Annual Kidney Congress
On behalf of the Conference Series LLC Ltd and the Organizing committee of Kidney 2018, we are pleased to welcome you to participate in the 3rd Annual Kidney Congress. The conference will be held from October 19 - 20, 2018 in New York, USA Major scientific sessions: Kidney Fluid, Electrolytes, Acid-Base Disorders Acute Kidney Injury (AKI) CKD -Mineral and Bone Disorders Chronic Kidney Disease (CKD) Kidney and Bladder stones Dialysis and Renal Care Urology/Urinary Tract Infections Kidney Transplantation Geriatric-Genetic Kidney
Asia-Pacific Kidney Detox Market Report 2018
Worldwide Market Reports added Latest Research Report titled “Asia-Pacific Kidney Detox Market Report 2018” In this report, the Asia-Pacific Kidney Detox market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (Units), revenue (Million USD), market share and growth
Kidney Stones Market - Global Forecast To 2022
Kidney stones are normal urinary tract disorders. Kidney stones are formed in an individual’s kidneys when ordinary substances in the urine turn out to be excessively concentrated. At the point when this happens, strong material can remain in the kidney or may move down through urinary tract, eventually passing out from the human body. The global kidney stone market is growing at a steady pace. The Global Kidney Stones market was